Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dorgormaa Gantumur"'
Autor:
Yasuo Hosouchi, Ryo Muranushi, Norio Kubo, Takahiro Yamanaka, Dorgormaa Gantumur, Norihiro Ishii, Ken Shirabe, Mariko Tsukagoshi, Norifumi Harimoto, Takamichi Igarashi, Kenichiro Araki, Kouki Hoshino, Kei Hagiwara, Akira Watanabe, Takehiko Yokobori, Hiroshi Tanaka
Publikováno v:
Annals of Surgical Oncology. 27:924-930
Pancreatic cancer tissue contains abundant stromal components, including extracellular matrix proteins such as tenascin C (TNC), which exists as large (TNC-L) and non-large splice variants. Here, we examined human pancreatic cancer specimens for the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9a48ed0d38fcc0302d3f8995173de50
https://doi.org/10.1245/s10434-019-07708-x
https://doi.org/10.1245/s10434-019-07708-x
Autor:
Norihiro Ishii, Akira Watanabe, Hiroyuki Kuwano, Norio Kubo, Bolag Altan, Takahiro Yamanaka, Takehiko Yokobori, Takamichi Igarashi, Yasuo Hosouchi, Kenichiro Araki, Dorgormaa Gantumur, Ken Shirabe, Mariko Tsukagoshi
Publikováno v:
Oncotarget
Pancreatic cancer is a highly malignant tumor type with poor outcomes, and elucidation of the mechanisms involved in cancer progression and therapeutic resistance is critical. FBXW7 is a key regulator of tumor malignant potential, and its substrate M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ccab6c58837ace4f280fc9229f56ed7
https://doi.org/10.18632/oncotarget.22634
https://doi.org/10.18632/oncotarget.22634
Autor:
Kei Hagiwara, Takehiko Yokobori, Norio Kubo, Norifumi Harimoto, Akira Watanabe, Atsushi Masamune, Hiroyuki Kuwano, Kenichiro Araki, Takamichi Igarashi, Tadashi Handa, Ken Shirabe, Takahiro Yamanaka, Norihiro Ishii, Mariko Tsukagoshi, Kazuo Umezawa, Dorgormaa Gantumur
Publikováno v:
Cancer Science
Despite recent advances in cancer treatment, pancreatic cancer is a highly malignant tumor type with a dismal prognosis and it is characterized by dense desmoplasia in the cancer tissue. Cancer-associated fibroblasts (CAF) are responsible for this fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::481279fcf0ac7cfc0c43116aa9c37d3c
https://pubmed.ncbi.nlm.nih.gov/30353606
https://pubmed.ncbi.nlm.nih.gov/30353606
Autor:
Ken Shirabe, Akira Watanabe, Hiroyuki Kuwano, Takahiro Yamanaka, Mariko Tsukagoshi, Norihiro Ishii, Kazunobu Suzuki, Navchaa Gombodorj, Dorgormaa Gantumur, Norio Kubo, Takehiko Yokobori, Yasuo Hosouchi, Takamichi Igarashi, Kenichiro Araki, Masahiko Nishiyama, N. Harimoto, Kei Hagiwara
Publikováno v:
Anticancer research. 38(2)
Background Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related deaths worldwide. Stathmin 1 (STMN1) suppression was reported to reduce cellular viability and migration potential. However, no previous studies have addressed wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16a2348a320984221ff1d01f45cba405
https://pubmed.ncbi.nlm.nih.gov/29374725
https://pubmed.ncbi.nlm.nih.gov/29374725
Autor:
Mariko Tsukagoshi, Kenichirou Araki, Ryo Muranushi, Akira Watanabe, Takahiro Yamanaka, Dorgormaa Gantumur, Ken Shirabe, Norihiro Ishii, Takamichi Igarashi, Kouki Hoshino, Norio Kubo, N. Harimoto, Kei Hagiwara
Publikováno v:
Annals of Oncology. 30:v20
Background The microenvironment such as cancer associated fibroblasts (CAFs) was reported to be involved in progression of intrahepatic cholangiocarcinoma (ICC). Nintedanib (BIBF1120) is a tyrosine kinase inhibitor of PDGFR, FGFR and VEGFR which is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4e334c35648ac6fbe326ed8c782c03c
https://doi.org/10.1093/annonc/mdz238.068
https://doi.org/10.1093/annonc/mdz238.068